Success Metrics

Active Trials

3(43%)

Phase Distribution

Ph phase_2

43%

Ph phase_3

43%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 2Efficacy & side effects

3(50.0%)

Phase 3Large-scale testing

3(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(4)

Other(3)

Detailed Status

Recruiting2

unknown2

Suspended1

Not yet recruiting1

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

N/A

Most Advanced

Phase 3

Trials by Phase

Phase 23 (50.0%)

Phase 33 (50.0%)

Trials by Status

suspended114%

recruiting229%

unknown229%

not_yet_recruiting114%

active_not_recruiting114%

Recent Activity

3 active trials

Showing 5 of 7

recruiting

The OBSERVE Protocol

NCT06725277

active_not_recruitingphase_2

Single-dose Ketamine Treatment to Improve Depression in Mild Cognitive Impairment

NCT06069843

recruitingphase_2

Clinical Trials (7)

Showing 7 of 7 trials

NCT06725277

The OBSERVE Protocol

Recruiting

NCT06069843Phase 2

Single-dose Ketamine Treatment to Improve Depression in Mild Cognitive Impairment

Active Not Recruiting

NCT04195256Phase 2

Intranasal Dexmedetomidine Plus Ketamine for Procedural Sedation

Recruiting

NCT06228391Phase 2

Ketamine Treatment for PTSD and MDD in TBI

Not Yet Recruiting

NCT03751423Phase 3

Intravenous Ketamine for Pain Control During First Trimester Surgical Abortion

Suspended

NCT04013958Phase 3

Comparison of Treatment by IM Ketamine to IV Ketamine in Patients With Renal Colic

Unknown

NCT02828566Phase 3

Intranasal Ketamine for Procedural Sedation

Unknown

All 7 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 7